Search

Burcelin, Remy, Valerie Crivelli, Christophe Perrin, Anabela Da Costa, James Mu, Barbara Kahn, Morris Birnbaum, Ronald Kahn, Peter Vollenweider, and Bernard Thorens. 2003. “GLUT4, AMP Kinase, But Not the Insulin Receptor, Are Required for Hepatoportal Glucose Sensor-Stimulated Muscle Glucose Utilization”. J Clin Invest 111 (10): 1555-62.

Van Maldergem, Magré, Khallouf, Gedde-Dahl, Delépine, Trygstad, Seemanova, et al. 2002. “Genotype-Phenotype Relationships in Berardinelli-Seip Congenital Lipodystrophy”. J Med Genet 39 (10): 722-33.

Shiojima, Ichiro, Mikkael Yefremashvili, Zhengyu Luo, Yasuko Kureishi, Akihiro Takahashi, Jingzang Tao, Anthony Rosenzweig, Ronald Kahn, Dale Abel, and Kenneth Walsh. 2002. “Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status”. J Biol Chem 277 (40): 37670-7.

Hamer, Foti, Emkey, Cordier-Bussat, Philippe, De Meyts, Maeder, Kahn, and Carpentier. 2002. “An Arginine to Cysteine(252) Mutation in Insulin Receptors from a Patient With Severe Insulin Resistance Inhibits Receptor Internalisation But Preserves Signalling Events”. Diabetologia 45 (5): 657-67.

Tseng, Yu-Hua, Kohjiro Ueki, Kristina Kriauciunas, and Ronald Kahn. 2002. “Differential Roles of Insulin Receptor Substrates in the Anti-Apoptotic Function of Insulin-Like Growth Factor-1 and Insulin”. J Biol Chem 277 (35): 31601-11.

Softic, Samir, Manoj Gupta, Guo-Xiao Wang, Shiho Fujisaka, Brian O’Neill, Tata Nageswara Rao, Jennifer Willoughby, et al. 2018. “Divergent Effects of Glucose and Fructose on Hepatic Lipogenesis and Insulin Signaling”. J Clin Invest 128 (3): 1199.

Merry, Troy, Doreen Kuhlow, Beate Laube, Doris Pöhlmann, Andreas Pfeiffer, Ronald Kahn, Michael Ristow, and Kim Zarse. 2017. “Impairment of Insulin Signalling in Peripheral Tissue Fails to Extend Murine Lifespan”. Aging Cell 16 (4): 761-72.

Ferris, Heather, and Ronald Kahn. 2016. “Unraveling the Paradox of Selective Insulin Resistance in the Liver: The Brain-Liver Connection”. Diabetes 65 (6): 1481-3.

Softic, Samir, David Cohen, and Ronald Kahn. 2016. “Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease”. Dig Dis Sci 61 (5): 1282-93.

Lagarrigue, Sylviane, Isabel Lopez-Mejia, Pierre-Damien Denechaud, Xavier Escoté, Judit Castillo-Armengol, Veronica Jimenez, Carine Chavey, et al. 2016. “CDK4 Is an Essential Insulin Effector in Adipocytes”. J Clin Invest 126 (1): 335-48.